Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage

Volume: 358, Issue: 20, Pages: 2127 - 2137
Published: May 15, 2008
Abstract
Background Intracerebral hemorrhage is the least treatable form of stroke. We performed this phase 3 trial to confirm a previous study in which recombinant activated factor VII (rFVIIa) reduced growth of the hematoma and improved survival and functional outcomes. Methods We randomly assigned 841 patients with intracerebral hemorrhage to receive pla­ cebo (268 patients), 20 μg of rFVIIa per kilogram of body weight (276 patients), or 80 μg of...
Paper Details
Title
Efficacy and Safety of Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage
Published Date
May 15, 2008
Volume
358
Issue
20
Pages
2127 - 2137
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.